Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:EMBDL
Clear all filters
Embassy Developments retains 78-acre Kadugodi land possession after Karnataka HC ruling
neutral
ET Markets - Industry 58d ago

Embassy Developments retains 78-acre Kadugodi land possession after Karnataka HC ruling

Embassy East Business Park retains possession of 78 acres in Bengaluru's Kadugodi Industrial Area. The Karnataka High Court overturned a Karnataka Industrial Areas Development Board order for land resumption. This ruling allows Embassy Developments to proceed with its planned business park.

3PLANDEMBDLFinancial ServicesRealty
This smallcap real estate stock rallied 51% in 3 days. What’s behind the surge?
positive
ET Markets - Stocks 65d ago

This smallcap real estate stock rallied 51% in 3 days. What’s behind the surge?

Embassy Developments shares surged 51% in three days after the NCLAT overturned an earlier order admitting the company into insolvency proceedings. The rally added over Rs 3,293 crore to its market value, taking its market capitalisation close to Rs 9,730 crore.

ABRELEMBDLSMALLCAPTRELVALUEFinancial ServicesForest Materials
NCLAT sets aside NCLT insolvency order against Embassy Developments
positive
ET Markets - Industry 68d ago

NCLAT sets aside NCLT insolvency order against Embassy Developments

Embassy Developments has won a significant legal battle. The National Company Law Appellate Tribunal has cancelled an earlier order that placed the company into insolvency proceedings. This ruling brings an end to the corporate insolvency resolution process. The developer's operations and projects remain unaffected. This positive development follows strong financial performance, with substantial pre-sales reported for the fiscal year.

EMBDLJMFINANCILRPPINFRAConstructionFinancial Services
NEWS
positive
Business Standard - Markets 93d ago

Embassy Developments hits the roof after Q4 pre-sales surge over 80% YoY

Embassy Developments locked in upper circuit of 5% at Rs 52.71 after the company's pre-sales jumped 89% to Rs 2,632 crore in Q4 FY26 compared with Rs 1,392 crore in Q3 FY26.

EMBDLRealty
NEWS
neutral
Business Standard - Markets 122d ago

Embassy Developments sells 500 units of Embassy Verde Phase II project

Achieves topline of Rs 495 cr

EMBDLRealty
Momentum Stocks: Coforge, Cigniti Tech, Purple United rally
positive
Moneycontrol NaNd ago

Momentum Stocks: Coforge, Cigniti Tech, Purple United rally

A few stocks saw sharp intraday moves and hit upper circuits. Media Matrix Worldwide, DCM Shriram Fine Chemicals, Embassy Developments were locked in the upper band, reflecting strong demand and limited supply—often a sign of bullish near-term sentiment.

CIGNITITECCOFORGEDCMDCMSHRIRAMDCMSILDCMSRINDDSFCLEMBDLHTMEDIAJGCHEMMMWLMOMENTUMPURPLEUTEDTECHZTECHChemicalsDiversified
Stocks to Watch Today: Orchid Pharma, HCL Tech, EMS, Silver Touch, Knack Packaging, Ganesh Infraworld, IdeaForge, Embassy Developments in focus on 8 July
positive
Moneycontrol NaNd ago

Stocks to Watch Today: Orchid Pharma, HCL Tech, EMS, Silver Touch, Knack Packaging, Ganesh Infraworld, IdeaForge, Embassy Developments in focus on 8 July

Stocks to Watch, 8 July: Stocks like Embassy Developments, InterGlobe Aviation, SpiceJet, Ganesh Infraworld, IdeaForge Technology, HCL Technologies, Silver Touch Technologies, EMS, 3i Infotech, Restaurant Brands Asia, IOL Chemicals and Pharmaceuticals, Cochin Shipyard, and Knack Packaging will be in focus on July 8.

3IINFOLTDBIOFILCHEMCOCHINSHIPEMBDLEMSLIMITEDFOCUSGANESHINHCLTECHIDEAFORGEINDIGOIOLCPJBCHEPHARMJGCHEMORCHPHARMARBASILVERSILVERTUCTECHZTECHCapital GoodsChemicals
Buzzing Stocks: Embassy Developments jumps 4% on robust Q1 pre-sales; Orchid Pharma rallies 9% on Russia licensing pact
positive
Moneycontrol NaNd ago

Buzzing Stocks: Embassy Developments jumps 4% on robust Q1 pre-sales; Orchid Pharma rallies 9% on Russia licensing pact

Orchid Pharma share price gained 9% after signing a licensing and supply agreement with Pharmasyntez JSC for Exblifep (cefepime/enmetazobactam).

EMBDLORCHPHARMAHealthcareRealty
Prev
1